EFFICACY OF LIDOCAINE SPRAY FOR PAIN RELIEF DURING EDOMETRIAL SAMPLING: A DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250210001

Enrollment

Registered

2025-02-10

Start date

2023-10-12

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

WOMAN WHO AGE MORE THAN 35 YEARS AND HAVE PROBLEM WITH ABNORMAL VIRGINAL BLEED ABNORMAL VAGINAL BLEED

Interventions

THE STUDY GROUP, CONSISTING OF PATIENTS WITH ABNORMAL UTERINE BLEEDING WHO RECIEVED 10% LIDOCAINE SPRAY FOR PAIN RELIEF DURING ENDOMETRIAL BIOPSY ,THE CONTROL GROUP, CONSISTING OF PATIENTS WITH ABNOR

Experimental Drug,Placebo Comparator Drug

STUDY GROUP,CONTROL GROUP

Eligibility

Sex/Gender

Female

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. WOMEN OVER THE AGE OF 35 WHO PRESENTED WITH ABNORMAL UTERINE BLEEDING AND REQUIRED ENDOMETRIAL TISSUE FOR PATHOLOGICAL EXAMINATION. 2. PARTICIPANTS HAD TO BE ABLE TO SPEAK, READ, WRITE, AND UNDERSTAND THE THAI LANGUAGE.

Exclusion criteria

Exclusion criteria: 1. A HISTORY OF LIDOCAINE ALLERGY. 2. PREGNANCY. 3. PELVIC INFECTION. 4. ABNORMAL BLOOD CLOTTING OR USE OF ANTICOAGULANTS. 5. CERVICAL STENOSIS, OR ABNORMAL UTERINE ANATOMY. 6. PARTICIPANTS WHO HAD USED ANY PAIN MEDICATIONS WITHIN ONE DAY PRIOR TO THE APPOINTMENT OR ON THE DAY OF THE PROCEDURE WERE EXCLUDED FROM THE STUDY.

Design outcomes

Primary

Measure	Time frame
PAIN SCORE DURING PROCEDURE VISUAL ANALOG SCALE	—

Secondary

Measure	Time frame
PAIN SCORE 15 MIN AFTER INTERVENTION VISUAL ANALOG SCALE	—

Countries

Thailand

Contacts

Public ContactPATOM JAKKABUT

PHRAE HOSPITAL, DEPARTMENT OF OBGYN

PATOMJAKKABUT@GMAIL.COM0972399653

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026